Fmr LLC lowered its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD – Free Report) by 42.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 68,255 shares of the medical instruments supplier’s stock after selling 49,915 shares during the quarter. Fmr LLC’s holdings in Mettler-Toledo International were worth $102,361,000 at the end of the most recent reporting period.
Several other hedge funds have also recently made changes to their positions in the business. Family Firm Inc. purchased a new stake in shares of Mettler-Toledo International in the second quarter valued at approximately $25,000. Blue Trust Inc. raised its stake in Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 17 shares during the last quarter. Ashton Thomas Securities LLC acquired a new stake in Mettler-Toledo International during the 3rd quarter worth about $37,000. Rothschild Investment LLC purchased a new stake in Mettler-Toledo International during the 2nd quarter valued at about $42,000. Finally, Itau Unibanco Holding S.A. acquired a new position in shares of Mettler-Toledo International in the second quarter valued at about $42,000. 95.07% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on the company. Evercore ISI lifted their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Stifel Nicolaus dropped their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Wells Fargo & Company cut their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Finally, Robert W. Baird decreased their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, Mettler-Toledo International has an average rating of “Hold” and a consensus target price of $1,338.75.
Insider Activity
In related news, Director Elisha W. Finney sold 76 shares of the stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company’s stock, valued at $314,820. This represents a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Gerry Keller sold 140 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the sale, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. This represents a 95.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.
Mettler-Toledo International Stock Up 0.3 %
NYSE:MTD opened at $1,262.16 on Thursday. The stock has a market capitalization of $26.63 billion, a PE ratio of 34.03, a price-to-earnings-growth ratio of 4.15 and a beta of 1.13. Mettler-Toledo International Inc. has a 52 week low of $1,068.33 and a 52 week high of $1,546.93. The stock’s 50-day moving average price is $1,335.41 and its 200-day moving average price is $1,387.72.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. The business had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. Sell-side analysts expect that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.
About Mettler-Toledo International
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
See Also
- Five stocks we like better than Mettler-Toledo International
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Tesla Poised to Hit Record Highs This Holiday Season
- Using the MarketBeat Dividend Tax Calculator
- The Salesforce Rally is Just Getting Started: Here’s Why
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.